Role of T Cell TGFβ Signaling and IL-17 in Allograft Acceptance and Fibrosis Associated with Chronic Rejection
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Chronic allograft rejection (CR) is the main barrier to long-term transplant survival. CR is a progressive disease defined by interstitial fibrosis, vascular neointimal development, and graft dysfunction. The underlying mechanisms responsible for CR remain poorly defined. TGFβ has been implicated in promoting fibrotic diseases including CR, but is beneficial in the transplant setting due to its immunosuppressive activity. To assess the requirement for T cell TGFβ signaling in allograft acceptance and the progression of CR, we used mice with abrogated T cell TGFβ signaling as allograft recipients. We compared responses from recipients that were transiently depleted of CD4+ cells (that develop CR and express intragraft TGFβ) with responses from mice that received anti-CD40L mAb therapy (that do not develop CR and do not express intragraft TGFβ). Allograft acceptance and suppression of graft-reactive T and B cells were independent of T cell TGFβ signaling in mice treated with anti-CD40L mAb. In recipients transiently depleted of CD4+ T cells, T cell TGFβ signaling was required for the development of fibrosis associated with CR, long-term graft acceptance, and suppression of graft-reactive T and B cell responses. Furthermore, IL-17 was identified as a critical element in TGFβ-driven allograft fibrosis. Thus, IL-17 may provide a therapeutic target for preventing graft fibrosis, a measure of CR, while sparing the immunosuppressive activity of TGFβ.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TGF-β signaling and the fibrotic response
Leask, A., & Abraham, D. J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1273rev · Cited by 2,319 · cited 1×
“It has been reported that sustained production of TGF in tissues is a main contributor to the development of fibrosis (57, 81), but we have observed that gene transfer of TGF in syngeneic grafts fail to develop CR (45).”
BackgroundIL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Marie, J. C., Liggitt, D., & Rudensky, A. Y. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.012 · Cited by 480
Zhang, N., Schröppel, B., Lal, G., Jakubzick, C., Mao, X., Chen, D., Yin, N., Jessberger, R., Ochando, J. C., Ding, Y., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.022 · Cited by 411
Research works printed but not linked: 80
- 2008, Mechanisms of chronic rejection in cardiothoracic transplantation., 2980
- 2000, Mechanisms of chronic rejection., 517
- 2006, Therapeutic targets in the treatment of allograft fibrosis., 867
- 1997, Chronic remodeling pathology in grafts., 676
- 2000, Chronic allograft dysfunction: mechanisms and new approaches to therapy., 126
- 2004, An update on clinical outcomes in heart and lung transplantation., S68
- 2006, Transforming growth factor-β regulation of immune responses., 99
- 1992, Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease., 693
- 1993, Transforming growth factor-β1 knockout mice: a mutation in one cytokine gene causes a dramatic inflammatory disease., 3
- 2000, Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease., 171
- 2000, Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor βII receptor., 1187
- 2007, TGFβ signalling in control of T-cell-mediated self-reactivity., 443
- 2001, Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β., 629
- 2002, The role of IL-10 and TGFβ in the differentiation and effector function of T regulatory cells., 263
- 2003, Regulatory T cells in transplantation tolerance., 199
- 2005, Autoimmune disorders in Kabuki syndrome., 260
- 2008, CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGFβ-dependent manner., 1975
- 2003, Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGFβ induction of transcription factor Foxp3., 1875
- 2006, Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells., 235
- 2006, Transforming growth factor-β induces development of the TH17 lineage., 231
- 2006, TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells., 179
- 2008, TGFβ-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function., 236
- 2007, Development, cytokine profile and function of human interleukin 17-producing helper T cells., 950
- 2007, Th17 cells: effector T cells with inflammatory properties., 362
- 2007, IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells., 484
- 2008, Induction and effector functions of TH17 cells., 1051
- 2008, The biological functions of T helper 17 cell effector cytokines in inflammation., 454
- 2009, TGFβ and fibrosis in different organs-molecular pathway imprints., 746
- 2007, IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-β, NF-κB, and AP-1 activation., H3356
- 2008, Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts., H2078
- 2007, IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants., 3498
- 2001, IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines., 430
- 2007, Is cystic fibrosis a TH17 disease?., 221
- 2009, Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection., 309
- 2009, Th17-polarized immune response in a murine model of hypersensitivity pneumonitis and lung fibrosis., 657
- 2004, Tregs and transplantation tolerance., 1398
- 2007, Role and mechanisms of CD4+CD25+ regulatory T cells in the induction and maintenance of transplantation tolerance., 120
- 1998, A critical role for transforming growth factor-β in donor transfusion-induced allograft tolerance., 1920
- 1998, Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells., 1868
- 2007, A key role for TGFβ signaling to T cells in the long-term acceptance of allografts., 3648
- 2000, DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta1 in vascularized cardiac allografts: differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor α1., 1292
- 2005, Transforming growth factor-β1 gene transfer is associated with the development of regulatory cells., 2378
- 2006, Transforming growth factor β-induced connective tissue growth factor and chronic allograft rejection., 959
- 2002, Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses., 375
- 1973, Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection., 343
- 1994, Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells: implications for cellular and humoral responses., 576
- 1999, Cytokine regulation of chronic cardiac allograft rejection: evidence against a role for Th1 in the disease process., 1548
- 2008, The classical complement pathway in transplantation: unanticipated protective effects of C1q and role in inductive antibody therapy., 1622
- 1998, High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice., 906
- 2009, OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade., 379
- 2009, Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection., 1773
- 2008, Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells., 2037
- 2002, The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells., 323
- 1999, TGFβ and fibrosis., 1349
- 2007, TGFβ, cardiac fibroblasts, and the fibrotic response., 207
- 2000, The role of transforming growth factor β in chronic renal allograft nephropathy., 1759
- 2007, Antibody-mediated renal allograft rejection: diagnosis and pathogenesis., 1046
- 2009, Antibody-mediated rejection: treatment alternatives and outcomes., 34
- 2000, CD40-CD154 interactions in B-cell signaling., 73
- 2001, Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice., 727
- 2004, Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection., 311
- 2005, Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers., 2778
- 2001, Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation., 37672
- 2004, Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants., 6003
- 2004, Cutting edge: TGFβ induces a regulatory phenotype in CD4+CD25− T cells through Foxp3 induction and down-regulation of Smad7., 5149
- 2006, TGFβ1, a “Jack of all trades”: the link with pro-inflammatory IL-17-producing T cells., 358
- 2006, Regulatory T cells in transplantation., 111
- 2008, IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice., 1023
- 2007, Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma., 682
- 2004, Regulatory T cells and organ transplantation., 119
- 2004, Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts., 326
- 1999, Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies., 904
- 2007, Achieving donor-specific hyporesponsiveness is associated with FoxP3+ regulatory T cell recruitment in human renal allograft infiltrates., 4901
- 2005, Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor., 1037
- 2002, Identification of regulatory T cells in tolerated allografts., 1641
- 2005, T cells that cannot respond to TGFβ escape control by CD4+CD25+ regulatory T cells., 737
- 2006, T regulatory cells and migration., 1518
- 1990, Biological and clinical aspects of interleukin 6., 443
- 2007, IL-6 signaling pathway in keloids: a target for pharmacologic intervention?., 6
- 1991, Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6., 686
Cited by
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
Host Responses in Tissue Repair and Fibrosis
Duffield, J. S., Lupher, M., Thannickal, V. J., & Wynn, T. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163930 · Cited by 624
Mechanisms of Rejection: Current Perspectives
Wood, K. J., & Goto, R. (2012) · Transplantation · doi:10.1097/tp.0b013e31823cab44 · Cited by 369
Shen, W., Guo, F., Jiang, H., Gao, J., Chen, W., Yu, Z., Yuan, J., Huang, M., Zong, M., Li, M., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116206 · Cited by 1
Metadata
- Authors
- Faust, S. M., Lu, G., Marini, B. L., Zou, W., Gordon, D., Iwakura, Y., Laouar, Y., & Bishop, D. K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12-01
- Volume
- 183
- Issue
- 11
- Pages
- 7297-7306
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2150750743
- Cited by
- 69
- References
- 4
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.